CDKN2B and renal carcinoma: Not only that, but in the studies of Dasgupta et al. and Luo et al., CDKN2B-AS1 is also considered to be a potential marker for renal cancer and osteosarcoma [24, 30], which also shows the significance of CDKN2B-AS1 on tumour diseases and suggests that we will be able to do so in the future.